INVESTMENT COUNSEL CO OF NEVADA

Position in GILD — Gilead Sciences, Inc.

CIK 2056576 LAS VEGAS, NV

Position in GILD

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$6,822

New position

Shares Held

54

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#2,200

of 2,266 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

INVESTMENT COUNSEL CO OF NEVADA holds $48,110 across 4 Drug Manufacturers - General names. GILD ranks #3 (14.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	100	$25,397
2	LLY	ELI LILLY & Co	8	$9,595
3	GILD	Gilead Sciences, Inc. This page	54	$6,822
4	MRK	Merck & Co., Inc.	49	$6,296

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,822	54	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.